Excessive serotonin release, not depletion, leads to memory impairments in rats

European Journal of Pharmacology

Volumn 295, Issue 1, 1996, Pages 7-17

  Santucci, Anthony C ^a,b,c   Knott, Peter J ^a,b   Haroutunian, Vahram ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c MANHATTANVILLE COLLEGE   (United States)

Author keywords

5 HT (5 hydroxytryptamine, serotonin); Alzheimer's disease; Memory; P Chloroamphetamine; Rat

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; CHLORAMPHETAMINE; NEUROTRANSMITTER; SEROTONIN;

ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN INJURY; CONTROLLED STUDY; DEPLETION; DORSAL RAPHE NUCLEUS; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MAZE TEST; MEMORY; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM; TASK PERFORMANCE;

EID: 0030051587     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00629-X     Document Type: Article

References (43)

1. Altman, H.J. and H.J. Normile, 1986, Enhancement of the memory of a previously learned aversive habit following pre-test administration of a variety of serotonergic antagonists in mice, Psychopharmacology (Berlin) 90, 24.
2. Altman, H.J. and H.J. Normile, 1987, Different temporal effects of serotonergic antagonists on passive avoidance retention, Pharmacol. Biochem. Behav. 28, 353.
3. Altman, H.J. and H.J. Normile, 1988, What is the nature of the role of the serotonergic nervous system in learning and memory?: Prospects for development of an effective treatment strategy for senile dementia, Neurobiol. Aging 9, 627.
4. Altman, H.J., D.A. Nordy and S.O. Ögren, 1984, Role of serotonin in memory: Facilitation by alaproclate and zimeldine, Psychopharmacology (Berlin) 84, 496.
5. Altman, H.J., W.S. Stone and S.O. Ögren, 1987, Evidence for a possible functional interaction between serotonergic and cholinergic mechanisms in memory retrieval, Behav. Neural Biol. 48, 49.
6. Arai, H., K. Kosaka and R. Iizuka, 1984, Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia, J. Neurochem. 44, 388.
7. Björklund, A., H.G. Baumgarten and A. Rensch, 1975, 5,7-Dihydroxytryptamine: improvement of its selectivity for serotonin neurons in the CNS by pretreatment with desipramine, J. Neurochem. 24, 833.
8. Brandeis, R., M. Sapir, Y. Kapon, G. Borelli, S. Cadel and B. Valsecchi, 1991, Improvement of cognitive function by MAO-B inhibitor 1-deprenyl in aged rats, Pharmacol. Biochem. Behav. 39, 297.
9. Cross, A.J., T.J. Crow, I.N. Ferrier, J.A. Johnson, S.R. Bloom and J.A. Crosellis, 1984, Serotonin receptor changes in dementia of the Alzheimer type, J. Neurochem. 43, 1574.
10. Cross, A.J., T.J. Crow, I.N. Ferrier and J.A. Johnson, 1986, The selectivity of the reduction of serotonin S2 receptors in Alzheimer-Type dementia, Neurobiol. Aging 7, 3.
11. Curcio, C.A. and T. Kemper, 1984, Nucleus raphe dorsalis in dementia of the Alzheimer type: Neurofibrillary changes and neuronal packing density, J. Neuropathol. Exp. Neurol. 43, 359.
12. Flood, J.F. and A. Cherkin, 1987, Fluoxetine enhances memory processing in mice, Psychopharmacology (Berlin) 93, 36.
13. Fuller, R.W., 1978, Structure-activity relationships among the halo-genated amphetamines, in: Serotonin Neurotoxin, eds. J.H. Jacoby and L.D. Lytle (New York Academy of Sciences, New York) p. 147.
14. German, D.C., C.L. White and D.R. Sparkman, 1987. Alzheimer's disease: Neurofibrillary tangles in nuclei that project to the cerebral cortex, Neuroscience 21, 305.
15. Gottfries, C.G., R. Adolfsson, S.M. Aquilonius, A. Carlsson, S.A. Eckernas, A. Norberg, L. Oreland, L. Svennerholm, A. Wiberg and B. Winblad, 1989, Biochemical changes in dementia disorders of the Alzheimer type (AD/SDAT), Neurobiol. Aging 4, 26.
16. Harvey, J.A., S.E. McMaster and L.M. Yunger, 1975, p-Chloroamphetamine: selective neurotoxic action in brain. Science 187, 841.
17. Ichimiya, Y., H. Arai, K. Kosaka and R. Iizuka, 1986, Morphological and biochemical changes in the cholinergic and monoaminergic systems in Alzheimer-type dementia, Acta Neuropathol. (Berlin) 70, 112.
18. Jäkälä, P., J. Sirviö, P. Riekkinen and P. Riekkinen. 1993, Effects of p-chlorophenylalanine and methysergide on the performance of a working memory task, Pharmacol. Biochem. Behav. 44, 411.
19. Le Bars, D., 1988, Serotonin and pain, in: Neuronal Serotonin, ed. N.N. Osbourne and M. Hamon (John Wiley and Sons) p. 171.
20. Lalonde, R. and V. Vikis-Freibergs, 1985, Manipulations of 5-HT activity and memory in the rat, Pharmacol. Biochem. Behav. 22, 377.
21. Markowska, A.L. and G.L. Wenk, 1991, Serotonin influences the behavioral recovery of rats following nucleus basalis lesions. Pharmacol. Biochem. Behav. 38, 731.
22. Maruyama, Y., T. Oshima and E. Nakajima, 1980, III. Simultaneous determination of catecholamines in rat brain by reversed-phase liquid chromatography with electrochemical detection. Life Sci. 26, 1115.
23. Miller, P.P., R.H. Cox, W.R. Snodgrass and R.P. Maickel, 1970, Comparative effects of p-chlorophenylalanine, p-chloroamphetamine and p-chloro-N-methylamphetamine on rat brain norepinephrine, serotonin and 5-hydroxyindole-3-acetic acid. Biochem. Pharmacol. 19, 435.
24. Mohs, R.C. and K.L. Davis, 1987, The experimental pharmacology of Alzheimer's disease and related disorders, in: Psychopharmacology: The Third Generation of Progress, ed. H.Y. Meltzer (Raven Press, New York) p. 921.
25. Normile, H.J., D.J. Jenden, D.M. Kuhn, W.A. Wolf and H.J. Altman, 1990, Effects of combined serotonin depletion and lesions of the nucleus basalis magnocellularis on acquisition of a complex spatial discrimination task in the rat, Brain Res. 536, 245.
26. Ögren, S.O., 1985, Central serotonin neurones in avoidance learning: Interactions with noradrenaline and dopamine neurones, Pharmacol. Biochem. Behav. 23, 107.
27. Ögren, S.O., 1986a, Serotonin receptor involvement in the avoidance learning deficit caused by p-chloroamphetamine-induced serotonin release, Acta Physiol. Scand. 126, 449.
28. Ögren, S.O., 1986b, Analysis of the avoidance learning deficit induced by the serotonin releasing compound p-chloroamphetamine, Brain Res. Bull. 16, 645.
29. Ögren, S.O., C. Johansson, O. Magnusson, 1985, Forebrain serotonergic involvement in avoidance learning, Neurosci. Lett. 58, 305.
30. Overton, D.A., 1978, Major theories of state dependent learning, in: Drug discrimination and state dependent learning, eds. B.T. Ho, D.W. Richards III and D.L. Chute (Academic Press, New York) p. 283.
31. Richter-Levin, G. and M. Segal, 1989, Spatial performance is severely impaired in rats with combined reduction of serotonergic and cholinergic transmission, Brain Res. 477, 404.
32. Richter-Levin, G. and M. Segal, 1991, The effects of serotonin depletion and raphe grafts on hippocampal electrophysiology and behavior, J. Neurosci. 11, 1585.
33. Riekkinen, M. and P. Riekkinen, 1995, Combined nicotinic and muscarinic cholinergic and serotonergic blockade selectively impair acquisition of spatial navigation, in: Alzheimer's and Parkinson's Diseases: Recent Developments, Third International Conference, eds. I. Hanin, A. Fisher and M. Yoshida (in press).
34. Riekkinen, P., J. Sirviö and P. Riekkinen, 1990, Interaction between raphe dorsalis and nucleus basalis magnocellularis in spatial learning, Brain Res. 527, 342.
35. Riekkinen, P., P. Jäkälä, J. Sirviö and P. Riekkinen, 1991a, The effects of increased serotonergic and decreased cholinergic activities on spatial navigation performance in rats, Pharmacol. Biochem. Behav. 39, 25.
36. Riekkinen, P., J. Sirviö, A. Valjakka, R. Miettinen and P. Riekkinen, 1991b. Pharmacological consequences of cholinergic plus serotonergic manipulations, Brain Res. 552, 23.
37. Riekkinen, P., M. Riekkinen, J. Sirviö and P. Riekkinen, 1992, Effects of concurrent nicotinic antagonist and PCPA treatments on spatial and passive avoidance learning, Brain Res. 575, 247.
38. Riekkinen, P., J. Sirviö and P. Riekkinen, 1993, Pharmacological consequences of nicotinergic plus serotonergic manipulations, Brain Res. 622, 139.
39. Sanders-Bush, E. and L.A. Steranka, 1978, Immediate and long-term effect of p-chloroamphetamine on brain amines, in: Serotonin Neurotoxin, eds. J.H. Jacoby and L.D. Lytle (New York Academy of Sciences, New York) p. 208.
40. Santucci, A.C., P.D. Kanof and V. Haroutunian, 1990, Serotonergic modulation of cholinergic systems involved in learning and memory in rats, Dementia 1, 151.
41. Santucci, A.C., E. Moody and J. Demetriades, 1995, Effects of scopolamine on spatial working memory in rats pretreated with the serotonergic depleter PCA, Neurobiol. Learn. Mem. 63, 286.
42. 1A receptors in memory, Pharmacol. Biochem. Behav. 27, 625.
43. Yates, C.M., J. Simpson and A. Gordon, 1986, Regional brain 5-hydroxytryptamine levels are reduced in senile Down's syndrome as in Alzheimer's disease, Neurosci. Lett. 65, 189.